Cyclobenzaprine Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-269 -
Package NDC
76420-269-01 -
Package NDC
76420-269-02 -
Package NDC
76420-269-07 -
Package NDC
76420-269-10 -
Package NDC
76420-269-15 -
Package NDC
76420-269-20 -
Package NDC
76420-269-30 -
Package NDC
76420-269-60 -
Package NDC
76420-269-90 -
Application number
ANDA071611 -
SPL ID
e7bfa09d-7e18-d2bf-e053-2995a90a9145 -
SPL set ID
f8dec4e2-3151-4a79-b194-a11a57ada0b6 -
UNII
0VE05JYS2P -
RxCUI
828299 -
RxCUI
828320 -
RxCUI
828348
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Cyclobenzaprine Hydrochloride
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cyclobenzaprine Hydrochloride",
"splId": "e7bfa09d-7e18-d2bf-e053-2995a90a9145",
"labels": [
{
"setId": "f8dec4e2-3151-4a79-b194-a11a57ada0b6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f8dec4e2-3151-4a79-b194-a11a57ada0b6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f8dec4e2-3151-4a79-b194-a11a57ada0b6"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 TABLET, FILM COATED in 1 BOTTLE (76420-269-01)",
"package_ndc": "76420-269-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "2 TABLET, FILM COATED in 1 BOTTLE (76420-269-02)",
"package_ndc": "76420-269-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "7 TABLET, FILM COATED in 1 BOTTLE (76420-269-07)",
"package_ndc": "76420-269-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "100 TABLET, FILM COATED in 1 BOTTLE (76420-269-10)",
"package_ndc": "76420-269-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "15 TABLET, FILM COATED in 1 BOTTLE (76420-269-15)",
"package_ndc": "76420-269-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "20 TABLET, FILM COATED in 1 BOTTLE (76420-269-20)",
"package_ndc": "76420-269-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (76420-269-30)",
"package_ndc": "76420-269-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (76420-269-60)",
"package_ndc": "76420-269-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (76420-269-90)",
"package_ndc": "76420-269-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20220903"
}
],
"productId": "76420-269_e7bfa09d-7e18-d2bf-e053-2995a90a9145",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "76420-269",
"deaSchedule": null,
"genericName": "Cyclobenzaprine Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CYCLOBENZAPRINE HYDROCHLORIDE",
"strength": "5 mg/1"
}
],
"applicationNumber": "ANDA071611",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210720",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"0VE05JYS2P"
],
"rxcui": [
"828299",
"828320",
"828348"
],
"spl_set_id": [
"f8dec4e2-3151-4a79-b194-a11a57ada0b6"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-269_e7bfa09d-7e18-d2bf-e053-2995a90a9145"